You just read:

Late-Breaking Results from XARELTO® (rivaroxaban) EINSTEIN CHOICE and GEMINI-ACS-1 Studies Among Research Accepted for Presentation at the American College of Cardiology 66th Annual Scientific Session

News provided by

Janssen Pharmaceuticals, Inc.

06 Mar, 2017, 08:00 ET